Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scienture Holdings (SCNX) Receivables - Other (2023 - 2025)

Historic Receivables - Other for Scienture Holdings (SCNX) over the last 3 years, with Q1 2025 value amounting to $3.8 million.

  • Scienture Holdings' Receivables - Other fell 5765.32% to $3.8 million in Q1 2025 from the same period last year, while for Mar 2025 it was $3.8 million, marking a year-over-year decrease of 5765.32%. This contributed to the annual value of $4.1 million for FY2024, which is 23794.1% up from last year.
  • Scienture Holdings' Receivables - Other amounted to $3.8 million in Q1 2025, which was down 5765.32% from $4.1 million recorded in Q4 2024.
  • Scienture Holdings' 5-year Receivables - Other high stood at $9.0 million for Q1 2024, and its period low was $1.2 million during Q4 2023.
  • For the 3-year period, Scienture Holdings' Receivables - Other averaged around $4.2 million, with its median value being $4.0 million (2024).
  • In the last 5 years, Scienture Holdings' Receivables - Other surged by 23794.1% in 2024 and then tumbled by 5765.32% in 2025.
  • Scienture Holdings' Receivables - Other (Quarter) stood at $1.2 million in 2023, then soared by 237.94% to $4.1 million in 2024, then fell by 7.49% to $3.8 million in 2025.
  • Its Receivables - Other stands at $3.8 million for Q1 2025, versus $4.1 million for Q4 2024 and $4.5 million for Q3 2024.